A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal ...

After the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once ...

Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics ...

Gilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

An Ipsen-commissioned survey has identified widespread problems with the transition from pediatric to adult healthcare, ...

After some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next ...

Gilead Sciences has broadened its partnership with Korean manufacturer Yuhan, agreeing to a 210 billion Korean won ($140 million) supply deal for active pharmaceutical ingredients (API) for an ...

Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers ...

As Eli Lilly moves to set up a mammoth manufacturing facility in Houston, it’s not the only U.S. pharma juggernaut with an ...

BeOne Medicines has tapped former professional soccer goalkeeper Tim Howard as the face of its first major corporate campaign ...

Already tracking at $5 billion in annual sales, Enhertu has secured two new FDA approvals to treat early breast cancer. But ...